ODDB.org: Open Drug Database

AstraZeneca AG - Imfinzi 500 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung

Swissmedic Registration	66548	Sequence	02
Product name	Imfinzi 500 mg/10 ml	Description	Konzentrat zur Herstellung einer Infusionslösung
ATC-Classification	L01FF03	ATC-Description
Introduction of Sequence	11.06.2018

Composition

durvalumabum 500 mg, histidinum, histidini hydrochloridum monohydricum, trehalosum dihydricum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 10 ml.

Packungsbestandteile

Galenic Form

Concentrate for infusion

Excipiens

Active Agent	Dose
Durvalumabum	500mg / 10ml

BAG: Active Agent	Dose
Durvalumabum	500 mg

Inactive agents
Histidin Hydrochloride Monohydrate
Histidine
Polysorbatum 80
Trehalosum Dihydricum

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
002		2123.36	2325.70	A	SL	Yes

2025	©ywesee GmbH